Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Goletz

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Anticancer Research|May 1, 2001
Expression of the Thomsen-Friedenreich (TF) antigen in the human placentaD U Richter, U Jeschke, J Makovitzky, et al.
Cancer Research|July 4, 1998
Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylationU Karsten, C Diotel, G Klich, et al.
Scandinavian Journal of Immunology|January 15, 2009
Modifying antibody specificity by chain shuffling of V / V between antibodies with related specificitiesP A Christensen, A Danielczyk, P Ravn, et al.
Beneficial Microbes|April 7, 2016
Impact of oral consumption of heat-treated Bacteroides xylanisolvens DSM 23964 on the level of natural TFα-specific antibodies in human adultsP Ulsemer, K Toutounian, G Kressel, et al.
Vaccine|October 18, 2005
A multivalent HIV-vaccine: development of a plasmid DNA for the expression of HIV envelope glycoproteins with hypervariable V3-loop domainsR Schilling, A Heil, K Langner, et al.
Glycobiology|November 18, 1997
A sequencing strategy for the localization of O-glycosylation sites of MUC1 tandem repeats by PSD-MALDI mass spectrometryS Goletz, B Thiede, F G Hanisch, et al.
International Immunopharmacology|April 19, 2019
Cluster binding studies with two anti-Thomsen-Friedenreich (anti-core-1, CD176, TF) antibodies: Evidence for a multiple TF epitopeA Flechner, G Butschak, A Löffler, et al.
International Immunopharmacology|January 31, 2021
Erratum to "Cluster binding studies with two anti-Thomsen-Friedenreich (anti-core-1, CD176) antibodies: Evidence for a quadruple epitope" [Int. Immunopharmacol. 72 (2019) 186-194]A Flechner, G Butschak, A Löffler, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2016
A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomasW Fiedler, S DeDosso, S Cresta, et al.
Anticancer Research|December 29, 2010
Clinical impacts of histological subtyping primary breast cancerP Fritz, S Klenk, S Goletz, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Anticancer Research|May 1, 2001
Expression of the Thomsen-Friedenreich (TF) antigen in the human placentaD U Richter, U Jeschke, J Makovitzky, et al.
Cancer Research|July 4, 1998
Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylationU Karsten, C Diotel, G Klich, et al.
Scandinavian Journal of Immunology|January 15, 2009
Modifying antibody specificity by chain shuffling of V / V between antibodies with related specificitiesP A Christensen, A Danielczyk, P Ravn, et al.
Beneficial Microbes|April 7, 2016
Impact of oral consumption of heat-treated Bacteroides xylanisolvens DSM 23964 on the level of natural TFα-specific antibodies in human adultsP Ulsemer, K Toutounian, G Kressel, et al.
Vaccine|October 18, 2005
A multivalent HIV-vaccine: development of a plasmid DNA for the expression of HIV envelope glycoproteins with hypervariable V3-loop domainsR Schilling, A Heil, K Langner, et al.
Glycobiology|November 18, 1997
A sequencing strategy for the localization of O-glycosylation sites of MUC1 tandem repeats by PSD-MALDI mass spectrometryS Goletz, B Thiede, F G Hanisch, et al.
International Immunopharmacology|April 19, 2019
Cluster binding studies with two anti-Thomsen-Friedenreich (anti-core-1, CD176, TF) antibodies: Evidence for a multiple TF epitopeA Flechner, G Butschak, A Löffler, et al.
International Immunopharmacology|January 31, 2021
Erratum to "Cluster binding studies with two anti-Thomsen-Friedenreich (anti-core-1, CD176) antibodies: Evidence for a quadruple epitope" [Int. Immunopharmacol. 72 (2019) 186-194]A Flechner, G Butschak, A Löffler, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2016
A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomasW Fiedler, S DeDosso, S Cresta, et al.
Anticancer Research|December 29, 2010
Clinical impacts of histological subtyping primary breast cancerP Fritz, S Klenk, S Goletz, et al.
Pageof 3